Shanghai Haohai details H and A share repurchase activity

Shanghai Haohai Biological Technology Co., Ltd. submitted its Next Day Disclosure Return on September 17, 2025, detailing recent changes in its issued shares and treasury shares. For its H-shares, the company's opening and closing balance of issued shares (excluding treasury shares) remained at 38,529,240. The company repurchased 18,400 H-shares on September 17, 2025, at HK$28 per share, totaling an aggregate price paid of HK$515,200. These repurchases account for 0.0233% of existing H-shares before the event and are yet to be cancelled.

Additionally, the company reported other repurchases for its H-shares that are not yet cancelled, including 67,400 shares on September 15, 2025, at HK$27.78, and 10,000 shares on September 16, 2025, at HK$27.68. The total number of shares authorized for repurchase under the mandate, granted on June 10, 2025, is 3,914,184, with 95,800 shares already repurchased on the Exchange.

For its A-shares, the opening and closing balance of issued shares (excluding treasury shares) remained at 190,203,760, with treasury shares at 3,848,095, leading to a total of 194,051,855 issued shares. There were no changes in A-shares on September 17, 2025.